191 related articles for article (PubMed ID: 15353829)
1. Intracoronary myocardial contrast echocardiography in a patient with drug refractory hypertrophic obstructive cardiomyopathy revealing extensive myocardium at risk for infarction with alcohol septal ablation.
Monakier D; Horlick E; Ross J; Woo A; Rakowski H; Schwartz L; Riley MP; Carver JR; Aggarwal K; James EA; Aziz S; Ramsdale DR
J Invasive Cardiol; 2004 Sep; 16(9):482-4. PubMed ID: 15353829
[No Abstract] [Full Text] [Related]
2. Quantification of changes in septal strain after alcohol septal ablation in hypertrophic obstructive cardiomyopathy-cases from the three-dimensional speckle tracking echocardiographic MAGYAR-path study.
Nemes A; Domsik P; Kalapos A; Gavallér H; Forster T; Sepp R
Echocardiography; 2013 Oct; 30(9):E289-91. PubMed ID: 23808936
[TBL] [Abstract][Full Text] [Related]
3. Unjailing of the septal perforator using a rotational atherectomy device prior to alcohol septal ablation in a patient with symptomatic hypertrophic obstructive cardiomyopathy.
Basir MB; Greenbaum A; O'Neill W
Catheter Cardiovasc Interv; 2014 Sep; 84(3):E26-9. PubMed ID: 24740801
[TBL] [Abstract][Full Text] [Related]
4. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
[TBL] [Abstract][Full Text] [Related]
5. Comparison of successful and failed alcohol septal ablations for obstructive hypertrophic cardiomyopathy.
Mayer SA; Anwar A; Grayburn PA
Am J Cardiol; 2003 Jul; 92(2):241-2. PubMed ID: 12860237
[No Abstract] [Full Text] [Related]
6. Alcohol septal ablation in the management of obstructive hypertrophic cardiomyopathy.
Spirito P; Rubartelli P
Ital Heart J; 2000 Nov; 1(11):721-5. PubMed ID: 11110513
[No Abstract] [Full Text] [Related]
7. Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy.
Monakier D; Woo A; Puri T; Schwartz L; Ross J; Jamorski M; Yang H; Liu Z; Vannan M; Wigle ED; Rakowski H
Am J Cardiol; 2004 Dec; 94(12):1515-22. PubMed ID: 15589007
[TBL] [Abstract][Full Text] [Related]
8. Alcohol septal ablation versus surgical myectomy: a patient with obstructive HCM.
La Canna G; Airoldi F; Capritti E; Grimaldi A; Colombo A; Alfieri O
Nat Clin Pract Cardiovasc Med; 2007 Oct; 4(10):570-6. PubMed ID: 17893685
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional contrast echocardiography-guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Moya Mur JL; Salido Tahoces L; Mestre Barcelo JL; Fernandez Golfín C; Zamorano Gómez JL
Eur Heart J Cardiovasc Imaging; 2014 Feb; 15(2):226. PubMed ID: 23988326
[No Abstract] [Full Text] [Related]
10. Apical infarct via septal collateralization complicating transluminal alcohol septal ablation for hypertrophic cardiomyopathy.
Parham WA; Kern MJ
Catheter Cardiovasc Interv; 2003 Oct; 60(2):208-11. PubMed ID: 14517926
[No Abstract] [Full Text] [Related]
11. Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy.
Pedone C; Vijayakumar M; Ligthart JM; Valgimigli M; Biagini E; De Jong N; Serruys PW; Ten Cate FJ
Int J Cardiovasc Intervent; 2005; 7(3):134-7. PubMed ID: 16243734
[TBL] [Abstract][Full Text] [Related]
12. Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy.
Carasso S; Woo A; Yang H; Schwartz L; Vannan MA; Jamorski M; Linghorne M; Wigle ED; Rakowski H
J Am Soc Echocardiogr; 2008 May; 21(5):493-9. PubMed ID: 17961980
[TBL] [Abstract][Full Text] [Related]
13. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area.
Faber L; Seggewiss H; Ziemssen P; Gleichmann U
Catheter Cardiovasc Interv; 1999 Aug; 47(4):462-6. PubMed ID: 10470478
[TBL] [Abstract][Full Text] [Related]
14. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Seggewiss H; Faber L; Ziemssen P
Cardiol Rev; 1999; 7(6):316-23. PubMed ID: 11208243
[TBL] [Abstract][Full Text] [Related]
15. Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Yoerger DM; Picard MH; Palacios IF; Vlahakes GJ; Lowry PA; Fifer MA
Am J Cardiol; 2006 May; 97(10):1511-4. PubMed ID: 16679095
[TBL] [Abstract][Full Text] [Related]
16. Pressure gradient response after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Veselka J
Kardiol Pol; 2006 Oct; 64(10):1161-2; author reply 1162. PubMed ID: 17214026
[No Abstract] [Full Text] [Related]
17. Induced septal infarction/nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy.
Kuhn HJ
Circulation; 1998 Feb; 97(7):708-9. PubMed ID: 9495312
[No Abstract] [Full Text] [Related]
18. Late in-hospital pressure gradient measurements improve prediction of long-term outcome of alcohol septal ablation in hypertrophic cardiomyopathy.
Keren A; Poteckin M; Mazouz B; Medina A; Banai S; Chenzbraun A; Khoury Z; Levin G
Isr Med Assoc J; 2007 Apr; 9(4):239-42. PubMed ID: 17491213
[TBL] [Abstract][Full Text] [Related]
19. Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy.
Reinhard W; Ten Cate FJ; Scholten M; De Laat LE; Vos J
Am J Cardiol; 2004 Apr; 93(8):1064-6. PubMed ID: 15081461
[TBL] [Abstract][Full Text] [Related]
20. Apical myocardial injury caused by collateralisation of a septal artery during ethanol septal ablation.
Agarwal SC; Purcell IF; Furniss SS
Heart; 2005 Jan; 91(1):e2. PubMed ID: 15604309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
